vs

Side-by-side financial comparison of Baxter International (BAX) and SCOTTS MIRACLE-GRO CO (SMG). Click either name above to swap in a different company.

Baxter International is the larger business by last-quarter revenue ($2.7B vs $1.5B, roughly 1.9× SCOTTS MIRACLE-GRO CO). SCOTTS MIRACLE-GRO CO runs the higher net margin — 16.3% vs -0.6%, a 16.9% gap on every dollar of revenue. On growth, Baxter International posted the faster year-over-year revenue change (3.0% vs -16.9%). Over the past eight quarters, SCOTTS MIRACLE-GRO CO's revenue compounded faster (10.2% CAGR vs -15.8%).

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.

The Scotts Miracle-Gro Company is an American multinational corporation headquartered in Marysville, Ohio, where O.M. Scott began selling lawn seed in 1868. The company manufactures and sells consumer lawn, garden and pest control products, as well as soilless indoor gardening equipment. In the U.S., the company manufactures Scotts, Miracle-Gro and Ortho brands. It also markets and distributes the herbicide Roundup in the U.S. and several international markets including China.

BAX vs SMG — Head-to-Head

Bigger by revenue
BAX
BAX
1.9× larger
BAX
$2.7B
$1.5B
SMG
Growing faster (revenue YoY)
BAX
BAX
+19.9% gap
BAX
3.0%
-16.9%
SMG
Higher net margin
SMG
SMG
16.9% more per $
SMG
16.3%
-0.6%
BAX
Faster 2-yr revenue CAGR
SMG
SMG
Annualised
SMG
10.2%
-15.8%
BAX

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
BAX
BAX
SMG
SMG
Revenue
$2.7B
$1.5B
Net Profit
$-15.0M
$238.6M
Gross Margin
33.0%
41.8%
Operating Margin
2.4%
27.5%
Net Margin
-0.6%
16.3%
Revenue YoY
3.0%
-16.9%
Net Profit YoY
61.2%
EPS (diluted)
$-0.03
$-2.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAX
BAX
SMG
SMG
Q1 26
$2.7B
$1.5B
Q4 25
$3.0B
$354.4M
Q3 25
$2.8B
$387.3M
Q2 25
$2.8B
$1.2B
Q1 25
$2.6B
$1.4B
Q4 24
$533.0M
$416.8M
Q3 24
$2.7B
$414.7M
Q2 24
$3.8B
$1.2B
Net Profit
BAX
BAX
SMG
SMG
Q1 26
$-15.0M
$238.6M
Q4 25
$-1.1B
$-125.0M
Q3 25
$-46.0M
Q2 25
$91.0M
$149.1M
Q1 25
$126.0M
$217.5M
Q4 24
$-512.0M
$-69.5M
Q3 24
$140.0M
Q2 24
$-314.0M
$132.1M
Gross Margin
BAX
BAX
SMG
SMG
Q1 26
33.0%
41.8%
Q4 25
19.4%
25.0%
Q3 25
33.5%
6.1%
Q2 25
35.3%
31.8%
Q1 25
32.8%
38.6%
Q4 24
25.0%
22.7%
Q3 24
38.3%
-7.1%
Q2 24
37.5%
29.5%
Operating Margin
BAX
BAX
SMG
SMG
Q1 26
2.4%
27.5%
Q4 25
-24.5%
-6.2%
Q3 25
6.1%
-38.8%
Q2 25
6.8%
18.1%
Q1 25
2.2%
24.3%
Q4 24
-25.5%
-12.2%
Q3 24
5.7%
-52.1%
Q2 24
-5.0%
16.6%
Net Margin
BAX
BAX
SMG
SMG
Q1 26
-0.6%
16.3%
Q4 25
-37.9%
-35.3%
Q3 25
-1.6%
Q2 25
3.2%
12.6%
Q1 25
4.8%
15.3%
Q4 24
-96.1%
-16.7%
Q3 24
5.2%
Q2 24
-8.2%
11.0%
EPS (diluted)
BAX
BAX
SMG
SMG
Q1 26
$-0.03
$-2.00
Q4 25
$-2.21
$-2.16
Q3 25
$-0.09
$-2.58
Q2 25
$0.18
$2.54
Q1 25
$0.25
$3.72
Q4 24
$-0.99
$-1.21
Q3 24
$0.27
$-4.21
Q2 24
$-0.62
$2.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAX
BAX
SMG
SMG
Cash + ST InvestmentsLiquidity on hand
$6.2M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
Total Assets
$3.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAX
BAX
SMG
SMG
Q1 26
$6.2M
Q4 25
$2.0B
$8.3M
Q3 25
$1.7B
$36.6M
Q2 25
$1.7B
$51.1M
Q1 25
$2.3B
$16.9M
Q4 24
$1.8B
$9.8M
Q3 24
$1.4B
$71.6M
Q2 24
$2.1B
$279.9M
Total Debt
BAX
BAX
SMG
SMG
Q1 26
$2.3B
Q4 25
$9.5B
Q3 25
$2.1B
Q2 25
Q1 25
Q4 24
$10.4B
Q3 24
$10.4B
$2.2B
Q2 24
$10.4B
Stockholders' Equity
BAX
BAX
SMG
SMG
Q1 26
Q4 25
$6.1B
$-500.6M
Q3 25
$7.2B
$-357.5M
Q2 25
$7.3B
$-170.9M
Q1 25
$7.1B
$-290.1M
Q4 24
$7.0B
$-479.5M
Q3 24
$7.9B
$-390.6M
Q2 24
$7.6B
$-146.2M
Total Assets
BAX
BAX
SMG
SMG
Q1 26
$3.4B
Q4 25
$20.1B
$3.0B
Q3 25
$21.1B
$2.7B
Q2 25
$21.0B
$3.1B
Q1 25
$21.3B
$3.5B
Q4 24
$25.8B
$3.2B
Q3 24
$26.7B
$2.9B
Q2 24
$26.3B
$3.5B
Debt / Equity
BAX
BAX
SMG
SMG
Q1 26
Q4 25
1.55×
Q3 25
Q2 25
Q1 25
Q4 24
1.49×
Q3 24
1.33×
Q2 24
1.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAX
BAX
SMG
SMG
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$76.0M
FCF MarginFCF / Revenue
2.8%
Capex IntensityCapex / Revenue
5.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAX
BAX
SMG
SMG
Q1 26
Q4 25
$584.0M
$-370.4M
Q3 25
$237.0M
$174.1M
Q2 25
$217.0M
$454.4M
Q1 25
$-193.0M
$188.1M
Q4 24
$488.0M
$-445.3M
Q3 24
$253.0M
$118.5M
Q2 24
$115.0M
$588.0M
Free Cash Flow
BAX
BAX
SMG
SMG
Q1 26
$76.0M
Q4 25
$-390.4M
Q3 25
$131.2M
Q2 25
$437.5M
Q1 25
$179.8M
Q4 24
$-474.6M
Q3 24
$101.9M
Q2 24
$574.8M
FCF Margin
BAX
BAX
SMG
SMG
Q1 26
2.8%
Q4 25
-110.2%
Q3 25
33.9%
Q2 25
36.8%
Q1 25
12.7%
Q4 24
-113.9%
Q3 24
24.6%
Q2 24
47.8%
Capex Intensity
BAX
BAX
SMG
SMG
Q1 26
5.1%
Q4 25
5.6%
Q3 25
11.1%
Q2 25
1.4%
Q1 25
0.6%
Q4 24
7.0%
Q3 24
4.0%
Q2 24
1.1%
Cash Conversion
BAX
BAX
SMG
SMG
Q1 26
Q4 25
Q3 25
Q2 25
2.38×
3.05×
Q1 25
-1.53×
0.86×
Q4 24
Q3 24
1.81×
Q2 24
4.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons